Table 1 Baseline clinical characteristics.
From: Multimodal machine learning for 5-year mortality prediction after percutaneous coronary intervention
Characteristic | Total patients | Survival group | Death group | P-value |
|---|---|---|---|---|
(n=10,353) | (n = 9149) | (n = 1204) | ||
Age, yr | \(63.1 \pm 10.2\) | \(62.1 \pm 10.0\) | \(69.5 \pm 9.7\) | <0.001 |
Male sex, n (%) | 7,734 (74.8%) | 6,762 (75.2%) | 972 (71.8%) | 0.005 |
Body-mass index, kg/m\(\vphantom{0}^{-2}\) | \(25.0 \pm 3.1\) | \(25.1 \pm 3.0\) | \(24.0 \pm 3.3\) | <0.001 |
Hypertension, n (%) | 6,688 (64.7%) | 5,865 (65.2%) | 823 (60.8%) | 0.107 |
Diabetes mellitus, n (%) | 3,385 (32.7%) | 2,979 (33.1%) | 406 (30.0%) | <0.001 |
Hyperlipidaemia, n (%) | 6,139 (59.4%) | 4,960 (55.2%) | 1,179 (87.1%) | <0.001 |
Current smoker, n (%) | 2,681 (25.9%) | 2,295 (25.5%) | 386 (28.5%) | <0.001 |
Chronic kidney disease, n (%) | 342 (3.3%) | 300 (3.3%) | 42 (3.1%) | <0.001 |
History of myocardial infarction, n (%) | 580 (5.6%) | 506 (5.6%) | 74 (5.5%) | <0.001 |
History of PCI, n (%) | 1,460 (14.1%) | 1,274 (14.2%) | 186 (13.7%) | 0.011 |
History of CABG, n (%) | 135 (1.3%) | 117 (1.3%) | 18 (1.3%) | 0.175 |
History of stroke/TIA, n (%) | 663 (6.4%) | 580 (6.5%) | 83 (6.1%) | <0.001 |
Left-ventricular ejection fraction, (%) | \(59.2 \pm 8.5\) | \(60.1 \pm 6.6\) | \(56.6 \pm 9.8\) | <0.001 |
Serum creatinine, mg/dL\(\vphantom{0}^{-1}\) | \(1.10 \pm 1.12\) | \(1.0 \pm 1.4\) | \(1.6 \pm 2.0\) | <0.001 |
